Table 5 Sensitivity, specificity, accuracy, and positive and negative predictive values of FDG-PET/CT and contrast-enhanced CT in lymph nodes, bone, lung, liver, and other visceral metastasis
From: Role of positron-emission tomography/computed tomography (PET/CT) in breast cancer
Sensitivity | Specificity | PPV | NPV | Accuracy | |
|---|---|---|---|---|---|
LN | |||||
PET/CT | 100.0% | 80.0% | 90.91% | 100.0% | 93.33% |
CT | 95.0% | 80.0% | 90.48% | 88.89% | 90.0% |
Bone | |||||
PET/CT | 91.67% | 100.0% | 100.0% | 94.74% | 96.67% |
CT | 75.0% | 94.44% | 90.0% | 85.0% | 86.67% |
Lung | |||||
PET/CT | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
CT | 72.73% | 73.68% | 61.54% | 82.35% | 73.33% |
Liver | |||||
PET/CT | 80.0% | 100.0% | 100.0% | 96.15% | 96.67% |
CT | 40.0% | 84.0% | 33.33% | 87.50% | 76.67% |
Other sites | |||||
PET/CT | 88.89% | 90.48% | 80.0% | 95.0% | 90.0% |
CT | 55.56% | 95.24% | 83.33% | 83.33% | 83.33% |